Institute for Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
Institute for Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA; Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
J Am Coll Cardiol. 2021 May 18;77(19):2413-2431. doi: 10.1016/j.jacc.2021.03.307.
Drug delivery is central to modern cardiovascular care, where drug-eluting stents, bioresorbable scaffolds, and drug-coated balloons all aim to restore perfusion while inhibiting exuberant healing. The promise and enthusiasm of these devices has in some cases exceeded demonstration of efficacy and even understanding of driving mechanisms. The authors review the means of drug delivery in each device, outlining how the technologies affect vascular behavior. They focus on how drug retention and response are governed by lesion morphology: lipid displacing drug-specific binding sites, calcium inhibiting diffusion, blocking thrombi or promoting luminal washout, and vascular healing steering hyperplastic developments. In this regard, the authors outline the fundamental impact of vascular structure on drug delivery and review the development of contemporary and future devices for coronary and peripheral intervention. They look toward a future where incorporating information on lesion distribution is central to therapeutic success and envision a transition toward lesion-specific treatment for improved interventional outcomes.
药物输送是现代心血管护理的核心,其中药物洗脱支架、生物可吸收支架和药物涂层球囊都旨在恢复灌注,同时抑制过度愈合。这些设备的前景和热情在某些情况下已经超出了疗效的证明,甚至超出了对驱动机制的理解。作者回顾了每种设备的药物输送方式,概述了这些技术如何影响血管行为。他们专注于药物保留和反应是如何受到病变形态的影响的:脂质置换药物特异性结合位点、钙抑制扩散、阻止血栓形成或促进管腔冲洗,以及血管愈合引导增生性发展。在这方面,作者概述了血管结构对药物输送的基本影响,并回顾了用于冠状动脉和外周介入的当代和未来设备的发展。他们展望了一个未来,其中纳入病变分布信息将是治疗成功的核心,并设想向针对病变的治疗转变,以改善介入治疗结果。